Expression of PD-L1 and PD-L2 in tumor samples was found to be highly congruent, and patients with PD-L1−positive and PD-L2−positive tumors were found to have longer OS than those with PD-L1−negative and PD-L2−negative tumors. This evidence concerns the gene PDCD1LG2 and neoplasm.